60 Degrees Pharmaceuticals, Inc.60 Degrees Pharmaceuticals, Inc.60 Degrees Pharmaceuticals, Inc.

60 Degrees Pharmaceuticals, Inc.

No trades
See on Supercharts

Price target

5.500.000.00%
The 1 analyst offering 1 year price forecasts for SXTP have a max estimate of — and a min estimate of —.

Analyst rating

Based on 2 analysts giving stock ratings to SXTP in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


SXTP EPS for the last quarter is −4.24 USD despite the estimation of −4.24 USD. In the next quarter EPS is expected to reach −0.71 USD. Track more of 60 Degrees Pharmaceuticals, Inc. financials and stay on top of what is up with the company.
In the next quarter 60 Degrees Pharmaceuticals, Inc. revenue is expected to reach ‪250.00 K‬ USD. Check out 60 Degrees Pharmaceuticals, Inc. revenue and earnings and make informed decisions.
According to analysts, SXTP price target is 5.50 USD with a max estimate of 5.50 USD and a min estimate of 5.50 USD. Check if this forecast comes true in a year, meanwhile watch 60 Degrees Pharmaceuticals, Inc. stock price chart and keep track of the current situation with SXTP news and stock market news.